Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
8
×
Tags
biotech
europe blog main
8
×
life sciences
8
×
national blog main
clinical trials
national
boston blog main
cancer
fda
national top stories
san francisco blog main
boston top stories
brexit
drugs
eli lilly
europe
europe top stories
falsified medicines
indiana blog main
indiana top stories
innovation
labeling
mhra
new york blog main
novartis
regulations
san francisco top stories
uk
abbvie
allergan
biogen
blueprint medicines
boulder/denver blog main
boulder/denver top stories
cancer drugs
deerfield management
detroit blog main
detroit top stories
gilead sciences
ipo
What
medicines
8
×
plans
brexit
charting
choppy
course
dynamic
end
fda
ipo
new
period
post
regulation
regulatory
reveals
transition
uk
bio
cancer
covid
drug
roundup
acquisitions
activity
address
adults
allergan
announced
approval
approvals
approved
approves
biogen
biotech
black
blueprint
carries
ceo
certain
Language
unset
Current search:
medicines
×
photo
×
" life sciences "
×
" europe blog main "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System
@xconomy.com
4 years ago
UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System
@xconomy.com
4 years ago
UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines